Full Text
Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders

Abstract

Authors

C. Acquadro C. Perret B. Arnould

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×